Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells

Y. H. Hsiang, H. Y. Wu, Leroy-Fong Liu

Research output: Contribution to journalArticle

246 Citations (Scopus)

Abstract

The intracellular level of DNA topoisomerase II appears to be reversibly regulated by serum concentration in cultured primary human skin fibroblasts (HSF). Upon serum starvation, the intracellular level of topoisomerase II in HSF, as monitored by immunoblotting with anti-topoisomerase II antibodies, gradually decreased to a nondetectable level (less than 104 copies/cell) over a period of 72 h. Addition of 10% serum to the starved cells led to a gradual increase of the intracellular topoisomerase II to the original level (approximately 106 copies/cell) over a period of 24 h. The intracellular DNA topoisomerase II level in HSF is also sensitive to cell density; minimally a 7-fold decrease was observed when HSF were grown to saturation density in a constant serum concentration. Similarly, the intracellular levels of DNA topoisomerase II in other 'nontransformed' cells such as mouse NIH 3T3 and 3T6 cells are also sensitive to both the serum concentration and the cell density. In contrast, topoisomerase II levels in transformed cells such as HeLa cells, L1210 cells, and SV40 T-antigen-transformed COS-1 cells are maintained at high levels (approximately 106 copies/cell) and are much less sensitive to growth conditions. The topoisomerase II level in HeLa cells synchronized by a double thymidine block remained relatively constant (less than 2-fold difference) throughout the late G1, S, G2, and M phases of the cell cycle. Our results suggest that the level of DNA topoisomerase II is primarily regulated in the G0-G1 phase of the cell cycle and is elevated to a high level (approximately 106 copies/cell) in proliferating cells. In contrast, the intracellular levels of DNA topoisomerase I in these cells were largely unaffected by these growth conditions either in HSF or in HeLa cells.

Original languageEnglish
Pages (from-to)3230-3235
Number of pages6
JournalCancer Research
Volume48
Issue number11
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Type II DNA Topoisomerase
Cultured Cells
Fibroblasts
Skin
HeLa Cells
Serum
G1 Phase
Cell Cycle
Cell Count
Polyomavirus Transforming Antigens
NIH 3T3 Cells
Cell Cycle Resting Phase
Type I DNA Topoisomerase
G2 Phase
COS Cells
Growth
Starvation
S Phase
Immunoblotting
Cell Division

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. / Hsiang, Y. H.; Wu, H. Y.; Liu, Leroy-Fong.

In: Cancer Research, Vol. 48, No. 11, 1988, p. 3230-3235.

Research output: Contribution to journalArticle

@article{59e173227a5e45f4a19c113f3226696f,
title = "Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells",
abstract = "The intracellular level of DNA topoisomerase II appears to be reversibly regulated by serum concentration in cultured primary human skin fibroblasts (HSF). Upon serum starvation, the intracellular level of topoisomerase II in HSF, as monitored by immunoblotting with anti-topoisomerase II antibodies, gradually decreased to a nondetectable level (less than 104 copies/cell) over a period of 72 h. Addition of 10{\%} serum to the starved cells led to a gradual increase of the intracellular topoisomerase II to the original level (approximately 106 copies/cell) over a period of 24 h. The intracellular DNA topoisomerase II level in HSF is also sensitive to cell density; minimally a 7-fold decrease was observed when HSF were grown to saturation density in a constant serum concentration. Similarly, the intracellular levels of DNA topoisomerase II in other 'nontransformed' cells such as mouse NIH 3T3 and 3T6 cells are also sensitive to both the serum concentration and the cell density. In contrast, topoisomerase II levels in transformed cells such as HeLa cells, L1210 cells, and SV40 T-antigen-transformed COS-1 cells are maintained at high levels (approximately 106 copies/cell) and are much less sensitive to growth conditions. The topoisomerase II level in HeLa cells synchronized by a double thymidine block remained relatively constant (less than 2-fold difference) throughout the late G1, S, G2, and M phases of the cell cycle. Our results suggest that the level of DNA topoisomerase II is primarily regulated in the G0-G1 phase of the cell cycle and is elevated to a high level (approximately 106 copies/cell) in proliferating cells. In contrast, the intracellular levels of DNA topoisomerase I in these cells were largely unaffected by these growth conditions either in HSF or in HeLa cells.",
author = "Hsiang, {Y. H.} and Wu, {H. Y.} and Leroy-Fong Liu",
year = "1988",
language = "English",
volume = "48",
pages = "3230--3235",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells

AU - Hsiang, Y. H.

AU - Wu, H. Y.

AU - Liu, Leroy-Fong

PY - 1988

Y1 - 1988

N2 - The intracellular level of DNA topoisomerase II appears to be reversibly regulated by serum concentration in cultured primary human skin fibroblasts (HSF). Upon serum starvation, the intracellular level of topoisomerase II in HSF, as monitored by immunoblotting with anti-topoisomerase II antibodies, gradually decreased to a nondetectable level (less than 104 copies/cell) over a period of 72 h. Addition of 10% serum to the starved cells led to a gradual increase of the intracellular topoisomerase II to the original level (approximately 106 copies/cell) over a period of 24 h. The intracellular DNA topoisomerase II level in HSF is also sensitive to cell density; minimally a 7-fold decrease was observed when HSF were grown to saturation density in a constant serum concentration. Similarly, the intracellular levels of DNA topoisomerase II in other 'nontransformed' cells such as mouse NIH 3T3 and 3T6 cells are also sensitive to both the serum concentration and the cell density. In contrast, topoisomerase II levels in transformed cells such as HeLa cells, L1210 cells, and SV40 T-antigen-transformed COS-1 cells are maintained at high levels (approximately 106 copies/cell) and are much less sensitive to growth conditions. The topoisomerase II level in HeLa cells synchronized by a double thymidine block remained relatively constant (less than 2-fold difference) throughout the late G1, S, G2, and M phases of the cell cycle. Our results suggest that the level of DNA topoisomerase II is primarily regulated in the G0-G1 phase of the cell cycle and is elevated to a high level (approximately 106 copies/cell) in proliferating cells. In contrast, the intracellular levels of DNA topoisomerase I in these cells were largely unaffected by these growth conditions either in HSF or in HeLa cells.

AB - The intracellular level of DNA topoisomerase II appears to be reversibly regulated by serum concentration in cultured primary human skin fibroblasts (HSF). Upon serum starvation, the intracellular level of topoisomerase II in HSF, as monitored by immunoblotting with anti-topoisomerase II antibodies, gradually decreased to a nondetectable level (less than 104 copies/cell) over a period of 72 h. Addition of 10% serum to the starved cells led to a gradual increase of the intracellular topoisomerase II to the original level (approximately 106 copies/cell) over a period of 24 h. The intracellular DNA topoisomerase II level in HSF is also sensitive to cell density; minimally a 7-fold decrease was observed when HSF were grown to saturation density in a constant serum concentration. Similarly, the intracellular levels of DNA topoisomerase II in other 'nontransformed' cells such as mouse NIH 3T3 and 3T6 cells are also sensitive to both the serum concentration and the cell density. In contrast, topoisomerase II levels in transformed cells such as HeLa cells, L1210 cells, and SV40 T-antigen-transformed COS-1 cells are maintained at high levels (approximately 106 copies/cell) and are much less sensitive to growth conditions. The topoisomerase II level in HeLa cells synchronized by a double thymidine block remained relatively constant (less than 2-fold difference) throughout the late G1, S, G2, and M phases of the cell cycle. Our results suggest that the level of DNA topoisomerase II is primarily regulated in the G0-G1 phase of the cell cycle and is elevated to a high level (approximately 106 copies/cell) in proliferating cells. In contrast, the intracellular levels of DNA topoisomerase I in these cells were largely unaffected by these growth conditions either in HSF or in HeLa cells.

UR - http://www.scopus.com/inward/record.url?scp=0023927993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023927993&partnerID=8YFLogxK

M3 - Article

C2 - 2835157

AN - SCOPUS:0023927993

VL - 48

SP - 3230

EP - 3235

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 11

ER -